70 likes | 96 Views
The study segments Respiratory Care Devices industry in light of major classification such as product type, potential markets, application, and end-user.
E N D
Respiratory Care Devices Market To Reach USD 37.04 Billion By 2027
Market Summary The rise in the incidence of respiratory disorders, adaptation to new technological advances, new product launches, and strategic collaboration, rise in the patient pool are key factors contributing to the high CAGR of the Respiratory Care Devices market during the forecast period. Market Size – USD 18.41 Billion in 2019, Market Growth - CAGR of 9.0% Market Trends– Favorable regulatory policies. According to the current analysis of Reports and Data, the global Respiratory Care Devices Market valued at USD 18.41 Billion in 2019 and is expected to reach USD 37.04 billion by the year 2027, at a CAGR of 9.0%. Respiratory care devices are increasingly used in the treatment, monitoring, and diagnosis of respiratory disorders. These devices are given to the patients to improve the treatment process. The rise in lifestyle habits like smoking, consumption of alcohol, and an increase in the geriatric population is a significant factor boosting the market. Technological advances for new devices, regulatory approvals, product launches are further promoting market growth. The prevalence of air pollution, climate changes, dust, are also fueling the market growth. The rising prevalence of Respiratory diseases is snowballing all over the world. In 2017, according to the WHO, Respiratory diseases were considered to be the leading causes of death and disability in the world. Nearly 65 million people suffer from chronic obstructive pulmonary disease (COPD), and 3 million are expected to die from it each year, making it the third leading cause of death across the world. Moreover, approximately 334 million people suffer from asthma, the most common chronic disease of childhood, affecting 14% of all children globally. www.reportsanddata.com
Further key findings from the report suggest • Masimo, in the year 2017, received an FDA 510(k) clearance for Rad-97 pulse co-oximeter and had launched it in the US. Rad-97 consists of a multi-touch display, a small footprint, and easy configuration; it also comprises of WiFi and supported Bluetooth wireless connections to related compatible devices like thermometers, glucometers, and weight scales. • In the year 2018, Convexity Scientificlaunched its Flyp nebulizer for COPD and asthma patients it is a held handheld, the pocket-sized device was approved by the FDA in the year 2017. Convexity's nebulizer comprises an internal vibrating disk that produces an inhaled aerosol mist to deliver medication deep into patients' lungs. • CAIRE, in the year 2019, launched FreeStyle, it is a portable oxygen concentrator. It is being designed to deliver oxygen bolus as the user's respiratory rate. FreeStyle Comfort is designed to be comfortable for wear due to its unique ergonomic design. It has also met FAA guidelines for use on commercial air flights and also offers wireless connectivity.
Market Summary Key Players: Philips Healthcare (Netherlands), ResMed Inc. (US), Medtronic plc (Ireland), Masimo Corporation (US), Fisher & Paykel Healthcare Corporation Limited (New Zealand), Chart Industries (US), Drager AG (Germany), Invacare Corporation (US), Getinge AB (Sweden), Air Liquide (France), Hamilton Medical AG (Switzerland), Vyaire Medical (US), GE Healthcare (US), Nonin Medical Inc. (US), Apex Medical Corp. (Taiwan), Smiths Group (UK), Omron Healthcare Inc. (US), Allied Healthcare Products, Inc. (US), Teleflex Incorporated (US), DeVilbiss Healthcare LLC (US), Convexity Scientific (US), CAIRE (US), Oventus Medical's (Australia). Segmentation: For the purpose of this purpose, Reports and Data have segmented the Respiratory Care Devices market on the basis of products, indications, end use, and region Products Outlook (Revenuein Million USD; 2017–2027) •Therapeutic Devices •Monitoring Devices •Diagnostic Devices •Consumables and Accessories To look at the PDF Sample Report and get 30 minutes of a free consultation @ https://www.reportsanddata.com/sample-enquiry-form/2771 www.reportsanddata.com
Market Summary Indications Outlook (Revenue in Million USD; 2017–2027) •Chronic Obstructive Pulmonary Disease (COPD) •Asthma •Sleep Apnea •Infectious Disease •Lung Cancer •Tuberculosis •Idiopathic Pulmonary Fibrosis End Use Outlook (Revenue in Million USD; 2017–2027) •Hospitals •Home Care Settings •Ambulatory Care Centers Regional Outlook (Revenue in USD Million; 2018–2026) •North America •Europe •Asia Pacific •Middle East & Africa •Latin America Grab Your Report at an Impressive Discount! Please Click Here : https://www.reportsanddata.com/discount-enquiry-form/2771 www.reportsanddata.com
The report emphasizes the following key questions: Q.1.What are the most lucrative and promising growth prospects for the market? Q.2.Which sectors are expected to deliver a high growth rate and which industry aspects come into play in this advancement? Q.3.Which geographies are estimated to exhibit the highest growth and the underlying causes? Q.4.Which factors are impacting the future of the market and what are the driving factors? Q.5.What are the hurdles and challenges curtailing the industry’s growth in the forecast period? www.reportsanddata.com
About Us Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact Us: John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com